JP2006020964A - Medical agent storage sealing body, and method for forming the same - Google Patents

Medical agent storage sealing body, and method for forming the same Download PDF

Info

Publication number
JP2006020964A
JP2006020964A JP2004203656A JP2004203656A JP2006020964A JP 2006020964 A JP2006020964 A JP 2006020964A JP 2004203656 A JP2004203656 A JP 2004203656A JP 2004203656 A JP2004203656 A JP 2004203656A JP 2006020964 A JP2006020964 A JP 2006020964A
Authority
JP
Japan
Prior art keywords
bag
discharge port
drug
medicine
drug bag
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004203656A
Other languages
Japanese (ja)
Other versions
JP4599918B2 (en
Inventor
Shoichi Kitagawa
彰一 北川
Yasuhiro Muramatsu
康宏 村松
Yukio Iino
幸生 飯野
Mitsuharu Fujii
光春 藤井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP2004203656A priority Critical patent/JP4599918B2/en
Publication of JP2006020964A publication Critical patent/JP2006020964A/en
Application granted granted Critical
Publication of JP4599918B2 publication Critical patent/JP4599918B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Package Specialized In Special Use (AREA)
  • Packages (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To reliably exclude the possibility of an erroneous operation that administration is performed while a medical agent bag is not opened yet concerning a multi-chemical mixture type medical agent bag. <P>SOLUTION: The medical agent bag 10 is formed of a soft film like base material. The inner cavity of the bag 10 is divided into a plurality of divided chambers 20, 22 through a soft seal part 18. A discharge port 12 is arranged to face one divided chamber 20 and is provided with a communication hole 28 at one end 12-2 facing the inner cavity of the medical agent bag 10. The communication hole 28 is normally closed by a separable peel membrane 30 so as to prevent the discharge of a medical agent from the medical agent bag 10 to the discharge port 12. The peel membrane 30 is firmly stuck onto the opposite surface of a plastic film constituting the medical agent bag, is deformed integrally with the opening deformation of the medical agent bag 10 at the moment of opening the soft seal part 18, and separated from the discharge port 12. The communication hole 28 is opened to the inner cavity of the medical agent bag so that the medical agent is discharged. <P>COPYRIGHT: (C)2006,JPO&NCIPI

Description

この発明は複数薬剤を分離状態で薬剤バッグのそれぞれの隔室に収容しておき、点滴や透析時に隔室間の弱シール部を開通させ、薬剤を混合して使用するようにした薬剤収納封止体及び薬剤収納封止体の形成方法に関するものである。   In this invention, a plurality of medicines are stored in respective compartments of the medicine bag in a separated state, and a weak seal portion between the compartments is opened during infusion or dialysis so that the medicines are mixed and used. The present invention relates to a method for forming a stationary body and a medicine storage sealing body.

点滴や透析などのための医療用混合型薬液封止体として多液混合型のものがある。多液混合型薬液封止体においては、軟弱フィルムを素材とする薬剤バッグの内部空洞は弱シール部によってそれぞれ異なった薬液を収容する複数の隔室に分離されている。薬剤バッグの外周には、プラスチック成型品としての薬液排出口が設けられ、薬液排出口は筒状に形成され、その内部空洞は一端側で一方の隔室に開口しているが、他端にはゴム栓が設けられている。患者への薬液の投与に先立って薬剤バッグを外側から加圧することによって弱シール部が開通せしめられ、薬剤バッグの内部空洞は一室となるため2種類の薬液は混合され、点滴用チューブに接続された輸液セットの穿刺針によりゴム栓を穿刺し、薬剤バッグよりの薬液の投与が可能となる。   There is a multi-liquid mixed type medical sealant for medical use for infusion or dialysis. In the multi-liquid mixed type liquid medicine sealed body, the internal cavity of the medicine bag made of a soft film is separated by a weak seal portion into a plurality of compartments each containing different liquid medicines. On the outer periphery of the drug bag, a chemical solution discharge port as a plastic molded product is provided, the chemical solution discharge port is formed in a cylindrical shape, and its internal cavity opens to one compartment on one end side, but on the other end Is provided with a rubber stopper. Prior to the administration of the drug solution to the patient, the weak seal is opened by pressurizing the drug bag from the outside, and the internal cavity of the drug bag becomes a single chamber, so the two types of drug solutions are mixed and connected to the infusion tube The rubber plug is punctured by the puncture needle of the infusion set thus made, and the drug solution can be administered from the drug bag.

この種の医療用混合型薬液封止体においては薬液の投与に先立って弱シール部の開通を行うことにより両液を混合せしめる作業は必須であり、他方、弱シール部の開通を行わないままで薬液排出口におけるゴム栓の穿刺を行うと、薬液排出口側の隔室における薬液のみが投与されてしまうという誤操作の可能性があった。この問題点に対処する従来技術として、薬剤バッグの内部空洞を二つの隔室に分離する第1の弱シール部に加えて、薬液排出口の直前に第2の弱シール部を設け、第1の弱シール部の開通に要する圧力に対して第2の第2の弱シール部を同等若しくはそれ以上とすることにより、第1の弱シール部次いで第2の弱シール部の順序で開通されるようにし、これにより薬液の混合後に排出が行われるようにしたものが提案されている(特許文献1参照)。
特開2004−661号公報
In this type of medical mixed-type liquid medicine sealed body, it is indispensable to mix the two liquids by opening the weak seal part before administration of the chemical liquid, while the weak seal part is not opened. When the rubber stopper is punctured at the chemical solution outlet, there is a possibility of an erroneous operation in which only the chemical solution in the compartment on the chemical solution outlet side is administered. As a conventional technique for coping with this problem, in addition to the first weak seal portion that separates the internal cavity of the drug bag into two compartments, a second weak seal portion is provided immediately before the chemical solution outlet, By making the second second weak seal portion equal to or higher than the pressure required to open the weak seal portion, the first weak seal portion and then the second weak seal portion are opened in this order. Thus, there has been proposed a method in which discharge is performed after mixing of chemicals (see Patent Document 1).
JP 2004-661 A

特許文献1の技術は二つの隔室を分離する第1の弱シール部に加えて薬液排出口の直前に第2の弱シール部を設け、これらの弱シール部を順次開通させることで未混合のままの薬液の投与は防止しうるが、弱シール部を2個所設けているため、製造工程が複雑化し、コスト増となり、ユーザ側に2段階の加圧による開通作業を強いることになり、作業性としては必ずしも良くなかった。また、薬剤バッグの加圧の仕方によっては第1の弱シール部→第2の弱シール部の順序によって必ずしも開通されるとは限らず、薬液排出口側の第2の弱シール部が先に開通されてしまうと、投与作業にそのまま移行してしまう可能性があり、この場合は未混合で1液のみ投与されてしまう結果となる。   In the technique of Patent Document 1, in addition to the first weak seal portion that separates the two compartments, a second weak seal portion is provided immediately before the chemical solution discharge port, and these weak seal portions are sequentially opened so that they are not mixed. However, since the two weak seals are provided, the manufacturing process becomes complicated and the cost increases, and the user is forced to open the work by two stages of pressurization. The workability was not always good. In addition, depending on the method of pressurizing the medicine bag, the opening is not always performed in the order of the first weak seal portion → the second weak seal portion, and the second weak seal portion on the side of the chemical solution discharge port is the first. If it is opened, there is a possibility of shifting to the administration work as it is. In this case, only one solution is administered without mixing.

この発明は以上の問題点に鑑みてなされてものであり、未開通の状態では投与を行い得ない多液混合型の薬剤バッグの新規な構造を提供し、製造コストが低廉でありかつユーザ側の作業性が良好であるにもかかわらず、未混合のままで投与が行われてしまうという誤操作の可能性をより確実に排除することを目的とする。   The present invention has been made in view of the above-mentioned problems, and provides a novel structure of a multi-liquid mixed type drug bag that cannot be administered in an unopened state, is low in manufacturing cost, and is low on the user side. The object of the present invention is to more reliably eliminate the possibility of an erroneous operation in which administration is performed in an unmixed state despite the good workability.

請求項1に記載の発明によれば、軟弱可撓性素材にて形成された薬剤バッグの内部空洞を弱シール部により複数の隔室に区画し、それぞれの隔室に薬剤を封入し、複数の隔室の一つを臨ませつつ外周が薬剤バッグに流密装着された排出口及び通常状態において前記排出口を薬剤バッグの内部空洞に対して閉鎖する閉鎖手段を具備し、前記閉鎖手段は、使用時の弱シール部開通の瞬間に薬剤バッグ内に惹起される衝撃的な流体力を受けたときの薬剤バッグの拡開変形と協働することにより排出口の閉鎖状態を解除可能であることを特徴とする薬剤収納封止体が提供される。   According to the first aspect of the present invention, the internal cavity of the medicine bag formed of a soft and flexible material is partitioned into a plurality of compartments by the weak seal portion, and the medicine is sealed in each compartment. A discharge port whose outer periphery is flow-tightly attached to the drug bag while facing one of the compartments, and a closing means for closing the discharge port with respect to the internal cavity of the drug bag in a normal state, The closed state of the discharge port can be released by cooperating with the expanding deformation of the drug bag when receiving a shocking fluid force induced in the drug bag at the moment of opening the weak seal part during use. There is provided a medicine container sealing body characterized in that.

請求項2に記載の発明によれば、軟弱可撓性素材にて形成された薬剤バッグの内部空洞を弱シール部により複数の隔室に区画し、それぞれの隔室に薬剤を封入し、複数の隔室の一つを臨ませつつ外周が薬剤バッグに流密装着された排出口及び通常状態において前記排出口を薬剤バッグの内部空洞に対して閉鎖する分離可能型の閉鎖部材を具備し、前記閉鎖部材は、薬剤バッグの対抗内面に一体に保持されたことを特徴とする薬剤収納封止体が提供される。   According to the second aspect of the present invention, the internal cavity of the medicine bag formed of a soft and flexible material is partitioned into a plurality of compartments by the weak seal portion, and the medicine is enclosed in each compartment. A discharge port whose outer periphery is flow-tightly attached to the drug bag while facing one of the compartments, and a detachable closing member that normally closes the discharge port with respect to the internal cavity of the drug bag, A drug storage sealing body is provided in which the closing member is integrally held on the opposing inner surface of the drug bag.

請求項3に記載の発明によれば、軟弱可撓性素材にて形成された薬剤バッグの内部空洞を弱シール部により複数の隔室に区画し、それぞれの隔室に薬剤を封入し、複数の隔室の一つを臨ませつつ外周が薬剤バッグに流密装着された排出口を備え、前記排出口は薬剤バッグの外側における薬剤取出部と薬剤バッグの内側における薬剤流入部と薬剤流入部を閉鎖する剥離可能な閉鎖部材とから成り、前記剥離可能な閉鎖部材は薬剤バッグを構成する軟弱可撓性素材の対抗面に一体に固着されていることを特徴とする薬剤収納封止体が提供される。   According to the third aspect of the present invention, the internal cavity of the medicine bag formed of a soft and flexible material is divided into a plurality of compartments by the weak seal portion, and the medicine is sealed in each compartment. A discharge port whose outer periphery is flow-tightly attached to the drug bag while facing one of the compartments, the discharge port being a drug extraction part outside the drug bag, a drug inflow part and a drug inflow part inside the drug bag A detachable closing member for closing the detachable closing member, wherein the detachable closing member is integrally fixed to a facing surface of a soft and flexible material constituting the drug bag. Provided.

請求項4に記載の発明によれば、軟弱可撓性素材にて形成された薬剤バッグの内部空洞を弱シール部により複数の隔室に区画し、それぞれの隔室に薬剤を封入し、複数の隔室の一つを臨ませつつ外周が薬液バッグに流密装着された排出口及び通常状態において前記排出口を閉鎖するように貼着された剥離膜を具備し、前記剥離膜は、薬剤バッグの対向面に、排出口に対する剥離膜の貼着より強固に貼着されたことを特徴とする薬剤収納封止体が提供される。   According to the fourth aspect of the present invention, the internal cavity of the medicine bag formed of a soft and flexible material is divided into a plurality of compartments by the weak seal portion, and the medicine is enclosed in each compartment, A discharge port whose outer periphery is flow-tightly attached to the chemical solution bag while facing one of the compartments, and a release film that is attached so as to close the discharge port in a normal state. Provided is a drug storage sealing body characterized in that it is adhered to the opposite surface of the bag more firmly than the adhesion of the release film to the discharge port.

請求項5に記載の発明によれば、軟弱可撓性素材にて形成された薬剤バッグの内部空洞を弱シール部により複数の隔室に区画し、それぞれの隔室に薬剤を封入し、外力により分離可能な作り付けの閉鎖部材を備えた排出口を複数の隔室の一つを臨ませつつ外周を薬剤バッグに流密装着し、排出口を閉鎖する閉鎖部材は薬剤バッグの対向内面に強固に固着されたことを特徴とする薬剤収納封止体が提供される。   According to the fifth aspect of the present invention, the internal cavity of the medicine bag formed of a soft and flexible material is partitioned into a plurality of compartments by the weak seal portion, the medicine is enclosed in each compartment, and the external force The discharge port with a built-in closure member that can be separated by the airtightly attached to the drug bag with the outer periphery facing one of the plurality of compartments, and the closure member that closes the discharge port is firmly attached to the opposite inner surface of the drug bag There is provided a medicine storage sealing body characterized in that it is fixed to the body.

請求項6に記載の発明によれば、軟弱可撓性素材にて形成され、内部空洞が弱シール部により複数の隔室に区画された薬剤バッグ及び剥離可能型の閉鎖部材により閉鎖された排出口を準備し、それぞれの隔室に薬剤を封入し、複数の隔室の一つを臨むように排出口をその外周において薬液バッグに流密装着すると共に、排出口に設けられた剥離可能型の閉鎖部材はこれに対向する薬剤バッグの内面に閉鎖部材の剥離に要するより大きな固着力にて固着するようにしたことを特徴とする薬剤収納封止体の形成方法が提供される。   According to the sixth aspect of the present invention, the medicine bag is formed of a soft and flexible material, and the internal cavity is partitioned by a weak seal portion into a plurality of compartments, and the drainage is closed by a peelable closure member. Prepare the outlet, enclose the medicine in each compartment, and attach the outlet to the chemical bag on the outer periphery so as to face one of the plural compartments, and the peelable type provided at the outlet The closing member is fixed to the inner surface of the drug bag opposite to the closing member with a larger fixing force required to peel off the closing member.

請求項1の発明の作用・効果を説明すると、閉鎖手段は通常は排出口を薬剤バッグの内部空洞に対して閉鎖し、薬剤バッグからの輸液はこれを行うことができない。弱シール部の開通は手のひら全体によって薬剤バッグを押圧することにより行われるが、弱シール部の開通時に押圧力が急激に解放されることにより薬剤バッグ内に衝撃的な薬液の流れが生じ、排出口の部位で薬剤バッグの大きな拡開変形が生じ、この拡開変形との協働により閉鎖手段による閉鎖状態は瞬時に解除され、排出口が薬剤バッグの内部空洞に連通され、輸液を開始することができる。そのため、この発明によれば、弱シール開通前における未混合の状態での誤作業の発生の防止をより確実に行うことができる。   The operation and effect of the invention of claim 1 will be described. Normally, the closing means closes the discharge port with respect to the internal cavity of the drug bag, and the infusion from the drug bag cannot do this. The opening of the weak seal part is performed by pressing the drug bag with the entire palm, but when the weak seal part is opened, the pressing force is abruptly released, which causes a shocking flow of the drug solution in the drug bag. A large expansion deformation of the drug bag occurs at the outlet portion, and in cooperation with this expansion deformation, the closed state by the closing means is instantly released, the discharge port communicates with the internal cavity of the drug bag, and infusion starts be able to. Therefore, according to the present invention, it is possible to more reliably prevent the occurrence of erroneous work in an unmixed state before the weak seal is opened.

請求項2の発明の作用・効果を説明すると、閉鎖部材は通常は排出口を薬剤バッグの内部空洞に対して閉鎖し、薬剤バッグからの輸液はこれを行うことができない。弱シール部の開通は手のひら全体によって薬剤バッグを押圧することにより行われるが、弱シール部の開通時に押圧力が急激に解放されることにより薬剤バッグ内に衝撃的な薬液の流れが生じ、排出口の部位で薬剤バッグの大きな拡開変形が生じ、この拡開変形を受けると、閉鎖部材は薬剤バッグと一体に変位するため排出口から離間変位することにより分離され、排出口が薬剤バッグの内部空洞に連通され、輸液を開始することができる。そのため、この発明によれば、弱シール開通前における未混合の状態での誤作業の発生の防止をより確実に行うことができる。また、排出口の閉鎖を分離型の閉鎖部材により行っており、弱シール部の開通時に排出口の閉鎖の解除に失敗しても、後発的に手操作により閉鎖部材を分離させ、輸液の続行に至らしめることができる。   The operation and effect of the invention of claim 2 will be described. The closing member normally closes the discharge port with respect to the internal cavity of the drug bag, and the infusion from the drug bag cannot perform this. The opening of the weak seal part is performed by pressing the drug bag with the entire palm, but when the weak seal part is opened, the pressing force is abruptly released, which causes a shocking flow of the drug solution in the drug bag. A large expansion deformation of the drug bag occurs at the exit portion. When this expansion deformation is received, the closure member is displaced integrally with the drug bag, so that it is separated by being displaced away from the discharge port, and the discharge port is separated from the drug bag. Communicating with the internal cavity, infusion can be initiated. Therefore, according to the present invention, it is possible to more reliably prevent the occurrence of erroneous work in an unmixed state before the weak seal is opened. In addition, the discharge port is closed by a separate type closing member. Even if the opening of the weak seal part fails to release the closing of the discharge port, the closing member is manually separated later to continue the infusion. Can be reached.

請求項3の発明の作用・効果を説明すると、排出口は薬剤バッグの外側に薬剤取出部を備え、薬剤バッグの内側における薬剤流入部を剥離可能な閉鎖部材により閉鎖しており、請求項2の発明と同様に弱シール部の開通と同時に排出口を確実に開放しうる上、薬剤バッグ外部のゴム栓のような取出部より薬液の排出作業を容易・確実に実施することができる。   The operation and effect of the invention of claim 3 will be described. The discharge port is provided with a medicine take-out portion on the outside of the medicine bag, and the medicine inflow portion on the inside of the medicine bag is closed by a detachable closing member. As in the case of the present invention, the discharge port can be surely opened simultaneously with the opening of the weak seal portion, and the discharge operation of the chemical solution can be easily and reliably performed from the extraction portion such as a rubber plug outside the drug bag.

請求項4の発明の作用・効果を説明すると、剥離膜は通常は排出口を薬剤バッグの内部空洞に対して閉鎖し、薬剤バッグからの輸液はこれを行うことができない。弱シール部の開通は手のひら全体によって薬剤バッグを押圧することにより行われるが、弱シール部の開通時に押圧力が急激に解放されることにより薬剤バッグ内に衝撃的な薬液の流れが生じ、排出口の部位で薬剤バッグの大きな拡開変形が生じ、この拡開変形を受けると、剥離膜は薬剤バッグに強固に貼着されているため薬剤バッグと一体に変位し、他方、排出口に対する剥離膜の貼着は弱いため、薬剤バッグとの一体の変位により剥離膜は排出口から剥離され、排出口が薬剤バッグの内部空洞に連通され、輸液を開始することができる。そのため、この発明によれば、弱シール開通前における未混合の状態での誤作業の発生の防止をより確実に行うことができる。また、剥離膜により排出口を閉鎖しているため、排出口を薬剤バッグにシールする作業と同時に薬剤バッグと剥離膜との貼着を同時的に行うことができ、薬剤収納封止体の形成工程が効率的となる。   The action and effect of the invention of claim 4 will be described. The release membrane normally closes the discharge port with respect to the internal cavity of the drug bag, and the infusion from the drug bag cannot perform this. The opening of the weak seal part is performed by pressing the drug bag with the entire palm, but when the weak seal part is opened, the pressing force is abruptly released, which causes a shocking flow of the drug solution in the drug bag. A large expansion deformation of the drug bag occurs at the exit portion, and when this expansion deformation is received, the peeling film is firmly attached to the drug bag, so that it is displaced integrally with the drug bag, and on the other hand, peeling to the discharge port Since the adhesion of the membrane is weak, the release membrane is peeled off from the discharge port by integral displacement with the drug bag, and the discharge port is communicated with the internal cavity of the drug bag, so that infusion can be started. Therefore, according to the present invention, it is possible to more reliably prevent the occurrence of erroneous work in an unmixed state before the weak seal is opened. In addition, since the discharge port is closed by the release film, the drug bag and the release film can be attached simultaneously with the operation of sealing the discharge port to the drug bag, thereby forming the drug storage sealing body. The process becomes efficient.

請求項5の発明の作用・効果を説明すると、閉鎖部材は排出口に作り付けとなっており、通常は排出口を薬剤バッグの内部空洞に対して閉鎖し、薬剤バッグからの輸液はこれを行うことができない。弱シール部の開通は手のひら全体によって薬剤バッグを押圧することにより行われるが、弱シール部の開通時に押圧力が急激に解放されることにより薬剤バッグ内に衝撃的な薬液の流れが生じ、排出口の部位で薬剤バッグの大きな拡開変形が生じ、この拡開変形を受けると、閉鎖部材は排出口から分離され、排出口が薬剤バッグの内部空洞に連通され、輸液を開始することができる。そのため、この発明によれば、弱シール開通前における未混合の状態での誤作業の発生の防止をより確実に行うことができる。また、排出口は作り付け構造の閉鎖部材を備えており、通常,空間部については,高圧蒸気滅菌により滅菌保証が難しいとされるが,排出口につき予め電子線又はガンマ線滅菌を行うことで無菌状態を確立した上で薬剤バッグに装着することができ,内溶液充填後,医薬品全体を高圧蒸気滅菌することで排出口につき予め所期の滅菌状態を確立した上で薬剤バッグに装着することができ、医薬品として必須の滅菌保証を容易かつ確実に得ることができる。   The operation and effect of the invention of claim 5 will be described. The closing member is built in the discharge port, and normally the discharge port is closed with respect to the internal cavity of the drug bag, and the infusion from the drug bag performs this. I can't. The opening of the weak seal part is performed by pressing the drug bag with the entire palm, but when the weak seal part is opened, the pressing force is abruptly released, which causes a shocking flow of the drug solution in the drug bag. A large expansion deformation of the drug bag occurs at the exit portion, and when this expansion deformation is received, the closing member is separated from the discharge port, and the discharge port communicates with the internal cavity of the drug bag, so that infusion can be started. . Therefore, according to the present invention, it is possible to more reliably prevent the occurrence of erroneous work in an unmixed state before the weak seal is opened. In addition, the outlet has a built-in closure member, and it is usually difficult to guarantee sterilization of the space by high-pressure steam sterilization. However, the outlet is sterilized by performing electron beam or gamma sterilization in advance. Can be attached to the drug bag after filling the inner solution, and the entire drug product can be attached to the drug bag after pre-establishing the desired sterilization condition for the outlet by autoclaving the whole drug. In addition, the sterilization guarantee essential for pharmaceuticals can be obtained easily and reliably.

請求項6の発明の作用・効果を説明すると、排出口を予め閉鎖部材により閉鎖した状態で排出口に対する薬剤バッグの封止が行われ、この封止時に薬剤バッグと閉鎖部材との対向面同士の固着も同時に行うことができ、薬剤収納封止体の形成を効率的に行うことができる。   The action and effect of the invention of claim 6 will be described. The medicine bag is sealed with respect to the discharge port in a state in which the discharge port is previously closed by the closing member. Can be fixed at the same time, and the formation of the medicine container sealing body can be performed efficiently.

図1及び図2において、医療用混合型薬液封止体は平坦状の薬剤バッグ10と排出口12とから構成される。薬剤バッグ10は厚さ200〜400ミクロンといったポリプロピレンフィルムやポリエチレンフィルムなどの軟弱フィルム(本発明の軟弱可撓性素材)を素材とする。ポリエチレンフィルムの場合に外周はその軟化温度より十分高い150℃といった高温にて加圧されることにより形成された強シール部14により封止され、矩形の袋状をなしている。強シール部14には懸垂孔16が穿設され、この懸垂孔16によって薬剤バッグ10を点滴台などに吊り下げ保持し、点滴や透析作業を行うことになる。   In FIG. 1 and FIG. 2, the medical mixed-type liquid medicine sealing body includes a flat medicine bag 10 and a discharge port 12. The drug bag 10 is made of a soft film (soft flexible material of the present invention) such as a polypropylene film or a polyethylene film having a thickness of 200 to 400 microns. In the case of a polyethylene film, the outer periphery is sealed by a strong seal portion 14 formed by being pressed at a high temperature such as 150 ° C., which is sufficiently higher than its softening temperature, and has a rectangular bag shape. A suspension hole 16 is formed in the strong seal portion 14, and the drug bag 10 is suspended and held by the suspension hole 16 on an infusion stand or the like to perform infusion or dialysis.

薬剤バッグ10の長さ方向における中間部位において全幅にわたって弱シール部18が延びており、弱シール部18によって薬剤バッグ10の表裏面が接着され、薬剤バッグ10の内部空洞は第1隔室20と第2隔室22とに区画される。第1隔室20に第1薬液が充填され、第2隔室22に第2薬液が充填される。弱シール部18は薬剤バッグ10を形成するポリエチレンフィルムの表裏面をその軟化温度よりやや高い130℃といった低温にて加圧することにより形成される。そのため、第1隔室20と第2隔室22にそれぞれの薬液を収容した状態で隔室20, 22の部位において薬剤バッグ10における薬液を外側より加圧することにより、強シール部14はそのままに弱シール部18を破壊・開通せしめ、第1薬液と第2薬液との混合を行うことができる。   The weak seal portion 18 extends over the entire width at an intermediate portion in the length direction of the drug bag 10, and the front and back surfaces of the drug bag 10 are bonded by the weak seal portion 18, and the internal cavity of the drug bag 10 is connected to the first compartment 20. It is partitioned into a second compartment 22. The first compartment 20 is filled with the first chemical solution, and the second compartment 22 is filled with the second chemical solution. The weak seal portion 18 is formed by pressurizing the front and back surfaces of the polyethylene film forming the drug bag 10 at a low temperature such as 130 ° C., which is slightly higher than the softening temperature. Therefore, the strong seal portion 14 is left as it is by pressurizing the drug solution in the drug bag 10 from the outside in the compartments 20 and 22 with the respective drug solutions stored in the first compartment 20 and the second compartment 22. The weak seal portion 18 can be broken and opened, and the first chemical solution and the second chemical solution can be mixed.

排出口12は、その形態を維持しうる剛性を有した肉厚を有したポリエチレン若しくはポリプロピレン,ポリオレフィンなどのプラスチック(薬剤バッグ10との溶着による密着性を得るため薬剤バッグ10と同種プラスチック素材とすることが好ましい)の成形品である。図2に示すように、排出口12は一端(外側端)12-1において拡径(図8に示すように拡径部は別体部品の溶着構造により実現することができる)していると共に、開口端にゴム栓24(本発明における薬剤取出部)が嵌着され、点滴時において、ゴム栓24に輸液セットの穿刺針26を穿刺することができる。排出口12は他端(内側端)12-2において矩形断面部(本発明における薬剤流入部)をなしており、矩形断面部12-2は端面12Aにおいて閉鎖しているが、上下側面12Bに開口するように連通孔28が穿設されている。連通孔28は剥離膜30(この発明の閉鎖部材)によって外面側より剥離可能に密封閉鎖されている。剥離膜30は素材としては薬剤バッグ10と溶着される面については同種のプラスチック素材を用い,また,排出口12と溶着される面については剥離可能な強度をコントロールできる素材を用いて(例えば外層ポリエチレン内層オレフィンコポリマーを含む多層フィルム)形成されており、その厚さとしては0.1〜0.5mm、好ましくは0.2〜0.4mmである。剥離膜30は排出口12の矩形断面部12-2の上下側面12Bに加熱溶着され、その結果連通孔28は密閉されて、排出口12の内部空洞は薬剤バッグ10の内部空洞との連通を阻止されている。側面12Bに対する剥離膜30の溶着温度としては、通常の状態においては、貫通孔28の密閉を維持することができるが、外力による剥離が容易な強度に設定されている。ポリエチレンの場合は弱シール部18を形成する際の薬剤バッグ10を構成するプラスチックフィルムの軟化温度よりやや高い130℃といった低温で行われる。剥離膜30は外面では薬剤バッグ10を形成するプラスチックフィルム10´の対抗面に溶着されている。薬剤バッグ10と剥離膜30との溶着は外力によっては容易に剥離し得ないように強力にされており、ポリエチレンの場合は強シール部14を形成する際の150℃といった高温により溶着されている。薬剤バッグ10の通常状態では、外面が薬剤バッグ10が対向内面に強固に貼着された剥離膜30により排出口12の連通孔28を密封閉鎖しており、薬剤バッグ10の対向面に貼着された剥離膜30はこの発明の閉鎖手段を構成する。剥離膜30は薬剤バッグ10に固着されているため、後述のように、薬剤バッグ10の開通時の薬剤バッグ10の拡開変形時にこれに協働して一体に変位するため剥離膜30は排出口から剥離せしめられ、連通孔28を露出させ、薬液の流通が許容される。   The discharge port 12 is made of a plastic material such as polyethylene, polypropylene, polyolefin or the like having a rigidity capable of maintaining its form (such as a plastic material similar to the drug bag 10 in order to obtain adhesion by welding with the drug bag 10). Is preferable). As shown in FIG. 2, the discharge port 12 has an enlarged diameter at one end (outer end) 12-1 (the enlarged diameter portion can be realized by a welded structure of separate parts as shown in FIG. 8). The rubber stopper 24 (the medicine extraction portion in the present invention) is fitted to the open end, and the puncture needle 26 of the infusion set can be pierced into the rubber stopper 24 at the time of infusion. The discharge port 12 has a rectangular cross section (the medicine inflow portion in the present invention) at the other end (inner end) 12-2, and the rectangular cross section 12-2 is closed at the end face 12A, A communication hole 28 is formed so as to open. The communication hole 28 is hermetically closed so as to be peelable from the outer surface side by a peeling film 30 (a closing member of the present invention). The release film 30 is made of a plastic material of the same type for the surface to be welded to the drug bag 10 and a material capable of controlling the peelable strength for the surface to be welded to the discharge port 12 (for example, the outer layer). A multilayer film containing a polyethylene inner layer olefin copolymer) is formed, and the thickness thereof is 0.1 to 0.5 mm, preferably 0.2 to 0.4 mm. The release film 30 is heat-welded to the upper and lower side surfaces 12B of the rectangular cross section 12-2 of the discharge port 12. As a result, the communication hole 28 is sealed, and the internal cavity of the discharge port 12 communicates with the internal cavity of the drug bag 10. It is blocked. As a welding temperature of the release film 30 to the side surface 12B, the through hole 28 can be kept sealed in a normal state, but is set to a strength that allows easy peeling by an external force. In the case of polyethylene, it is performed at a low temperature such as 130 ° C., which is slightly higher than the softening temperature of the plastic film constituting the drug bag 10 when the weak seal portion 18 is formed. The release film 30 is welded to the opposing surface of the plastic film 10 ′ that forms the drug bag 10 on the outer surface. Welding between the drug bag 10 and the release film 30 is strengthened so that it cannot be easily peeled off by an external force, and in the case of polyethylene, it is welded at a high temperature such as 150 ° C. when forming the strong seal portion 14. . In the normal state of the drug bag 10, the communication hole 28 of the discharge port 12 is hermetically closed with a release film 30 whose outer surface is firmly adhered to the inner surface of the drug bag 10, and is adhered to the opposite surface of the drug bag 10. The released release film 30 constitutes the closing means of the present invention. Since the release film 30 is fixed to the drug bag 10, as described later, the release film 30 is displaced in cooperation with the expansion when the drug bag 10 is expanded when the drug bag 10 is opened. It is peeled off from the outlet, the communication hole 28 is exposed, and the flow of the chemical solution is allowed.

次に、図1の薬剤収納封止体の形成方法について説明すると、内部空洞が弱シール部18により隔室20, 22に分離された 両端が開口した薬剤バッグを準備する。両端の開口部より夫々の隔室20, 22に薬剤を充填し、夫々の隔室20, 22への開口部を強シール14によって閉鎖する。薬剤の充填時、薬剤バッグ10に対する排出口12の強シールも行うが、これについて説明すると、薬剤バッグへの装着に先立ち排出口12に剥離膜30の低温溶着が行われ、連通孔28は剥離膜30により剥離可能に密閉された状態にある(ゴム栓24も装着済みとなっている)。そのため、排出口12は外部に対して完全に密封されており、予め電子線やガンマ線などにより内部を滅菌された密封空間としておくこともできる。そして、このように剥離膜30を装着した排出口12は薬剤バッグにおける隔室22への開口部に装着され、高温での溶着が行われる。この溶着の際に、薬剤バッグ10と剥離膜30との溶着も同時に行われる。即ち、溶着金型は薬剤バッグ10を構成するプラスチックフィルム10´を排出口の円筒部12-2に圧着する半割の第1の溶着部と、この第1の溶着部から一体に延出する半割の第2の溶着部とを備えており、排出口12の円筒部12-2に対する薬剤バッグ10を構成するプラスチックフィルム10´の溶着による強シール14の形成と同時に剥離膜30に対する薬剤バッグ10の対向内面の高温貼着とを同時に行うことができる。   Next, a method for forming the drug storage sealing body of FIG. 1 will be described. A drug bag having both internal cavities separated into compartments 20 and 22 by a weak seal portion 18 is prepared. The respective compartments 20 and 22 are filled with the drug from the openings at both ends, and the openings to the respective compartments 20 and 22 are closed by the strong seal 14. At the time of filling the medicine, the sealing of the discharge port 12 with respect to the medicine bag 10 is also performed. This will be explained. It is in a state where it is detachably sealed by the film 30 (the rubber plug 24 is already mounted). Therefore, the discharge port 12 is completely sealed with respect to the outside, and the inside can be made a sealed space sterilized with an electron beam or gamma ray in advance. And the discharge port 12 which mounted | wore with the peeling film | membrane 30 in this way is mounted | worn with the opening part to the compartment 22 in a chemical | medical agent bag, and welding at high temperature is performed. At the time of this welding, the drug bag 10 and the release film 30 are also welded at the same time. That is, the welding mold integrally extends from the first welded portion, which is a half of the first welded portion that presses the plastic film 10 ′ constituting the drug bag 10 onto the cylindrical portion 12-2 of the discharge port. A drug bag for the release film 30 at the same time as the formation of the strong seal 14 by welding the plastic film 10 ′ constituting the drug bag 10 to the cylindrical part 12-2 of the discharge port 12. Ten high-temperature sticking of the opposing inner surface can be performed simultaneously.

図2は薬剤バッグ10の弱シール部18が未開通の状態を示し、各隔室20, 22にそれぞれの薬液が個別的に収容され、隔室20, 22に収容される薬液の分だけ薬剤バッグ10は多少膨れている。しかしながら、剥離膜30によって排出口12の連通孔28は密閉されているため、仮にゴム栓24に輸液セットの穿刺針26を穿刺したとしても薬剤バッグ内の薬剤は排出口12より排出することはできない。   FIG. 2 shows a state where the weak seal portion 18 of the medicine bag 10 is not opened, and the respective chemical solutions are individually accommodated in the compartments 20 and 22, and the chemicals are contained by the amount of the chemical solution contained in the compartments 20 and 22. The bag 10 is somewhat swollen. However, since the communication hole 28 of the discharge port 12 is sealed by the release film 30, even if the puncture needle 26 of the infusion set is punctured into the rubber plug 24, the drug in the drug bag is not discharged from the discharge port 12. Can not.

薬剤バッグ10の開通のため薬剤バッグ10は上面より手のひらで矢印bのように強く加圧される(図2では隔室20側において薬剤バッグ10を加圧しているが隔室22の側を加圧しても両側を加圧してもよい)。薬剤バッグ10の加圧により弱シール部18に液圧が加わり、所定の圧力により弱シール部18は瞬時に破壊開通するに至る。加圧により薬剤バッグ10の内圧は高められており、弱シール部18の開通の開通によりこの高められた圧力が一気に放出されるため、衝撃的な薬液の流れが薬剤バッグ10内に惹起される。薬剤バッグ10内に惹起された衝撃的な薬液の流れを図5では矢印fにより模式的に示す。弱シール部18の開通の際に薬剤バッグ10内に惹起された急激な薬液の流れfは薬剤バッグ10を構成するプラスチックフィルム10´を図示のように拡開させ、薬剤バッグ10に強固に貼着された剥離膜30は薬剤バッグ10と共に変位するも貼着が弱い排出口12の側面12Bから剥離せしめられる。剥離膜30の剥離によって、薬剤バッグ10の内部空洞は連通孔28を介して排出口12の内部空洞に対して恒久的に連通され、ゴム栓24に穿刺される輸液セットより排出することができる。   In order to open the drug bag 10, the drug bag 10 is strongly pressed from the upper surface as shown by an arrow b in FIG. 2 (in FIG. 2, the drug bag 10 is pressurized on the compartment 20 side, but the compartment 22 side is added. Pressurize or pressurize both sides). The liquid pressure is applied to the weak seal portion 18 by pressurization of the medicine bag 10, and the weak seal portion 18 is instantaneously broken and opened by a predetermined pressure. The internal pressure of the drug bag 10 is increased by the pressurization, and the increased pressure is released at once by opening the weak seal portion 18, so that a shocking flow of the drug solution is induced in the drug bag 10. . In FIG. 5, the flow of the shocking chemical liquid that is induced in the drug bag 10 is schematically indicated by an arrow f. The sudden flow f of the drug solution induced in the drug bag 10 when the weak seal portion 18 is opened causes the plastic film 10 ′ constituting the drug bag 10 to expand as shown in the figure, and is firmly attached to the drug bag 10. The attached release film 30 is peeled off from the side surface 12B of the discharge port 12 which is displaced together with the drug bag 10 but weakly attached. By peeling off the release film 30, the internal cavity of the drug bag 10 is permanently connected to the internal cavity of the discharge port 12 through the communication hole 28, and can be discharged from the infusion set punctured by the rubber plug 24. .

以上の実施形態においては排出口12に対する剥離膜30の溶着温度は弱シール部18の形成時の溶着温度と同等であり、粘着力も同等であるため、弱シール18の開通時の薬液バッグの拡開(膨らみ)によって剥離膜30の剥離は同時的に行われることが殆どであるが、剥離膜30が排出口12から完全に剥離しない場合が万一あっても、薬液バッグ10の外側より指操作によって剥離膜30の剥離を行うことは容易であり、薬剤の開通に至らしめることができる。即ち、弱シール18の未開通時は夫々の隔室20, 22への薬液の充填率が相対的に高いため薬剤バッグ10を構成するプラスチックフィルムを外部から剥離操作しようとしても薬液に邪魔されるためその操作を行い難いが、弱シール18を開通させると、薬剤バッグ内での空間の占める割合が大きくなるため、液体に邪魔されることなくプラスチックフィルムを介して剥離膜30を剥離させるべく外部から操作することが容易となる。   In the above embodiment, the welding temperature of the release film 30 with respect to the discharge port 12 is the same as the welding temperature at the time of forming the weak seal portion 18 and the adhesive force is also equivalent, so that the chemical solution bag is expanded when the weak seal 18 is opened. In most cases, the peeling film 30 is peeled off simultaneously by opening (swelling), but even if the peeling film 30 is not completely peeled from the discharge port 12, it is possible to remove the finger from the outside of the chemical solution bag 10. It is easy to peel off the release film 30 by an operation, and the drug can be opened. That is, when the weak seal 18 is not opened, the filling rate of the chemical solution into the respective compartments 20 and 22 is relatively high, so that even if an attempt is made to peel off the plastic film constituting the drug bag 10 from the outside, the chemical solution is obstructed. Therefore, it is difficult to perform the operation, but if the weak seal 18 is opened, the proportion of the space in the drug bag increases, so that the peeling film 30 is peeled off through the plastic film without being disturbed by the liquid. It becomes easy to operate from.

図6及び図7はこの発明の第2の実施形態を示しており、排出口112の連通孔128は排出口112の円筒部に円周方向に離間して複数形成され、剥離膜130はこれらの連通孔128を閉塞するように排出口112の円筒部に1周巻かれ(図7参照)、相対的に低温にて溶着され、弱い貼着力にて貼着されている。そして、薬液バッグ10を構成する上下のプラスチックフィルム10は最外側端の部位で排出口112の円筒部に高温にて溶着され(強シール14を形成し)、この部位14に近接した部位で薬液バッグ10を構成するプラスチックフィルム10´は剥離膜130の外面には高温にて溶着され、強い貼着力に貼着されている。   6 and 7 show a second embodiment of the present invention. A plurality of communication holes 128 of the discharge port 112 are formed in the cylindrical portion of the discharge port 112 so as to be circumferentially separated, and the release film 130 is formed by these. The communication hole 128 is wound once around the cylindrical portion of the discharge port 112 (see FIG. 7), welded at a relatively low temperature, and stuck with a weak sticking force. The upper and lower plastic films 10 constituting the chemical solution bag 10 are welded to the cylindrical portion of the discharge port 112 at a portion at the outermost end at a high temperature (forms a strong seal 14), and the chemical solution is provided at a location close to this portion 14. The plastic film 10 ′ constituting the bag 10 is welded to the outer surface of the release film 130 at a high temperature and stuck to a strong sticking force.

この第2実施形態においても、剥離膜130は通常は排出口112を閉鎖し、薬剤バッグ10の内部空洞への薬剤バッグ10の連通を阻止し、薬剤バッグ10の弱シール部を開通する際の薬剤バッグ10の拡開変形と一体に剥離膜130は変位するため、剥離膜130は排出口112から剥離・分離され、連通孔128は開放されるため、排出口112は薬剤バッグ10の内部空洞に開口され、薬剤の排出が可能となる。この実施形態では剥離膜130は排出口112の円周方向に巻回されているため、排出口112に剥離膜130を溶着した後、薬剤バッグ10を構成する上下のプラスチックフィルム10´の対抗面に高温溶着する際に、薬液バッグに対する排出口112の円周方向の位置決めなしに薬剤バッグと剥離膜130との強シールのための溶着を実施することができ、薬剤収納封止体の形成工程をその分簡略化することができる。   Also in the second embodiment, the release film 130 normally closes the discharge port 112, prevents the drug bag 10 from communicating with the internal cavity of the drug bag 10, and opens the weak seal portion of the drug bag 10. Since the peeling film 130 is displaced integrally with the expansion deformation of the drug bag 10, the peeling film 130 is peeled and separated from the discharge port 112, and the communication hole 128 is opened, so that the discharge port 112 is an internal cavity of the drug bag 10. The medicine can be discharged. In this embodiment, since the release film 130 is wound in the circumferential direction of the discharge port 112, after the release film 130 is welded to the discharge port 112, the upper and lower plastic films 10 ′ constituting the drug bag 10 face each other. When high-temperature welding is performed, welding for strong sealing between the drug bag and the release film 130 can be performed without positioning the discharge port 112 in the circumferential direction with respect to the drug solution bag. Can be simplified accordingly.

以上の実施形態において、溶着された剥離膜30, 130を弱シール部18の開通時の薬剤バッグの拡開変形との協働により排出口12, 112から剥離させることで、排出口12, 112を薬剤バッグ10の内部空洞に連通させているが、剥離膜30, 130の溶着の代わりに、イージーピール性の接着剤を使用することも可能であり、また、排出口を部分的に薄肉などに一体形成することで、機械的に分離(破壊)可能に構成し、この分離可能部分を薬液バッグの対抗内面に高温溶着により固着するようにしてもよい。また、剥離膜を使用せずとも、脆弱シールにより、剥離可能に製造することもでき、このような態様も本件発明に含まれるものである。この場合も、弱シール部18の開通時における薬剤バッグの拡開変形により一体形成の薄肉部分が分離若しくは破壊せしめられ、薬剤バッグの内部空洞を排出口に連通せしめることができ、同様の作用・効果を達成しうる。連通孔128は、複数条設けることにより製造が容易となるとともに、良好な排出性を示す。連通孔の個数としては図では45度間隔で8個であるが、90度間隔で4個といったように必要に応じて個数を変更ことは任意である。また剥離膜を使わず、脆弱シールのみで製造することもこの発明の範囲に包含されることもいうまでもない。   In the above embodiment, the peeled release films 30 and 130 are peeled from the discharge ports 12 and 112 in cooperation with the expansion deformation of the drug bag when the weak seal portion 18 is opened. Is communicated with the internal cavity of the drug bag 10, but it is also possible to use an easy peel adhesive instead of welding the release films 30 and 130, and the discharge port is partially thin. It is possible to mechanically separate (break) and form the separable part to the inner surface of the drug solution bag by high-temperature welding. Moreover, it can also manufacture so that peeling is possible with a weak seal | sticker, without using a peeling film, and such an aspect is also included in this invention. Also in this case, the integrally formed thin portion is separated or destroyed by the expansion deformation of the drug bag when the weak seal portion 18 is opened, and the internal cavity of the drug bag can be communicated with the discharge port. The effect can be achieved. Providing a plurality of communication holes 128 facilitates the manufacture and exhibits good discharge characteristics. In the figure, the number of communication holes is eight at 45 ° intervals, but it is arbitrary to change the number as necessary, such as four at 90 ° intervals. Needless to say, manufacturing using only a fragile seal without using a release film is also included in the scope of the present invention.

図8は第3の実施形態を示す。この実施形態においては、排出口212は剛性のあるプラスチック素材にて筒状に形成された剛直基部260と、基部260から筒状に一体に延出し、可撓性のあるプラスチック素材にて形成された可撓性本体262(この発明の閉鎖部材)とから構成される。本体部262の一端フランジ部にキャップ部264が溶着され、キャップ部264にゴム栓213が嵌着される。可撓性本体262の先端262Aは扁平に圧潰することができ、その圧潰された部位における対向内面間は剥離膜230を介して低温にて溶着される。他方、薬剤バッグ10を構成する上下プラスチックフィルム10´は、可撓性本体262の対向外面に高温にて溶着される。   FIG. 8 shows a third embodiment. In this embodiment, the discharge port 212 is formed of a rigid base material 260 that is formed of a rigid plastic material in a cylindrical shape, and extends integrally from the base portion 260 in a cylindrical shape, and is formed of a flexible plastic material. And a flexible main body 262 (a closing member of the present invention). A cap part 264 is welded to one end flange part of the main body part 262, and a rubber plug 213 is fitted to the cap part 264. The distal end 262A of the flexible main body 262 can be flattened and the opposed inner surfaces of the collapsed portion are welded at a low temperature via the release film 230. On the other hand, the upper and lower plastic films 10 ′ constituting the drug bag 10 are welded to the opposing outer surface of the flexible main body 262 at a high temperature.

図8(イ)に示すように、通常時は、可撓性本体262の扁平化された先端262Aは対向内面で低温溶着されているため、排出口212は薬剤バッグ10の内部空洞に対して閉鎖され、たとえ輸液セットの穿刺針によりゴム栓213を穿刺したとしても薬剤の排出は阻止される。弱シール部の開通時に図8(ロ)に示すように、薬剤バッグ10は拡開変位するため、低温溶着された剥離膜230は破られ、可撓性本体262の先端262Aの対抗面は剥離され、排出口212は薬剤バッグ10の内部空洞に連通せしめられ、薬剤の排出が可能となる。   As shown in FIG. 8 (a), since the flattened tip 262A of the flexible main body 262 is usually welded at a low temperature on the opposing inner surface, the discharge port 212 is connected to the internal cavity of the drug bag 10 as shown in FIG. Even if the rubber stopper 213 is punctured by the puncture needle of the infusion set, the medicine is prevented from being discharged. As shown in FIG. 8B, when the weak seal portion is opened, since the drug bag 10 is expanded and displaced, the peeling film 230 that has been welded at low temperature is broken, and the opposing surface of the tip 262A of the flexible body 262 is peeled off. Then, the discharge port 212 is communicated with the internal cavity of the medicine bag 10 so that the medicine can be discharged.

図9は別の実施形態を示しており、剛性のあるプラスチック素材にて形成された排出口312の先端に軟弱プラスチックチューブ362の一端を高温溶着し、軟弱プラスチックチューブ362の他端362Aは扁平に潰し、対向内面を剥離膜330に低温溶着し、プラスチックチューブ362の扁平端部362Aの外面に薬剤バッグ10を構成するプラスチックフィルム10´の対抗面を高温溶着にて一体化したものである。この図9の実施形態の動作は図8の実施形態と同様であり、通常はプラスチックチューブ362の扁平端部362Aが低温溶着されていることにより薬剤バッグ10の内部からの輸液が排出口312への流入が阻止され、弱シールの開通時における薬剤バッグの開通時に薬剤排出口362との接続部(プラスチックチューブ362の扁平端部362A)において薬剤バッグ10が拡径変形することで、剥離膜330は破られ、プラスチックチューブ362の端部362Aは拡開され、薬剤バッグ10の内部からの薬液が排出口312へ流入することができるようになる。   FIG. 9 shows another embodiment, in which one end of the soft plastic tube 362 is welded to the tip of the discharge port 312 formed of a rigid plastic material at a high temperature, and the other end 362A of the soft plastic tube 362 is flattened. It is crushed, the opposite inner surface is welded to the release film 330 at a low temperature, and the opposing surface of the plastic film 10 ′ constituting the drug bag 10 is integrated with the outer surface of the flat end 362 A of the plastic tube 362 by high-temperature welding. The operation of the embodiment of FIG. 9 is the same as that of the embodiment of FIG. 8. Normally, the flat end 362A of the plastic tube 362 is welded at a low temperature, so that the infusion from the inside of the drug bag 10 is discharged to the discharge port 312. Is prevented from flowing in, and the drug bag 10 expands and deforms at the connecting portion (flat end 362A of the plastic tube 362) with the drug discharge port 362 when the drug bag is opened when the weak seal is opened. Is broken, and the end 362A of the plastic tube 362 is expanded, so that the drug solution from the inside of the drug bag 10 can flow into the discharge port 312.

以上の実施形態では薬剤バッグ10は薬液と薬液とを混合させるタイプであるが、薬液と粉状などの液状ではない薬剤とを混合させて使用するタイプの薬剤バッグにおいてもこの発明は実施可能である。   In the above embodiment, the drug bag 10 is a type in which a drug solution and a drug solution are mixed. However, the present invention can also be implemented in a type of drug bag that is used by mixing a drug solution and a non-liquid drug such as powder. is there.

図1はこの発明の薬剤収納封止体の平面図(図2のI方向矢視図)である。FIG. 1 is a plan view (a view taken in the direction of the arrow I in FIG. 2) of the medicine container sealing body of the present invention. 図2は図1の薬剤収納封止体の縦断面図(図1のII−II線に沿って現される矢視断面図)である。2 is a longitudinal cross-sectional view (a cross-sectional view taken along the line II-II in FIG. 1) of the medicine container sealing body in FIG. 図3は図2のIII−III線に沿って表される矢視断面図である。FIG. 3 is a cross-sectional view taken along the line III-III in FIG. 図4は図2のIV−IV線に沿って表される矢視断面図である。4 is a cross-sectional view taken along the line IV-IV in FIG. 図5は図1の薬剤収納封止体の部分図であるが、薬剤バッグの開通の瞬間における排出口に対する薬剤バッグの接続部の状態を示す。FIG. 5 is a partial view of the medicine container sealing body of FIG. 1, and shows the state of the connecting portion of the medicine bag with respect to the discharge port at the moment when the medicine bag is opened. 図6は第2実施形態において薬剤バッグに対する排出口の接続部の縦断面図である。FIG. 6 is a longitudinal cross-sectional view of a connection portion of a discharge port with respect to a medicine bag in the second embodiment. 図7は図6のVIII−VIII線に沿って表される矢視断面図である。FIG. 7 is a cross-sectional view taken along the line VIII-VIII in FIG. 図8は第2実施形態において薬剤バッグに対する排出口の接続部の縦断面図であり、(イ)は通常状態、(ロ)は弱シール部の開通時を示す。FIG. 8 is a longitudinal cross-sectional view of the connection portion of the discharge port with respect to the drug bag in the second embodiment, where (A) shows a normal state and (B) shows when the weak seal portion is opened. 図9は第3実施形態における薬剤バッグに対する排出口の接続部の縦断面図である。FIG. 9 is a longitudinal cross-sectional view of the connection portion of the discharge port with respect to the medicine bag in the third embodiment.

符号の説明Explanation of symbols

10…薬剤バッグ
12…排出口
14…強シール部
16…懸垂孔
18…弱シール部
20…第1隔室
22…第2隔室
24…ゴム栓
28…連通孔
30…剥離膜






DESCRIPTION OF SYMBOLS 10 ... Drug bag 12 ... Discharge port 14 ... Strong seal part 16 ... Suspension hole 18 ... Weak seal part 20 ... 1st compartment 22 ... 2nd compartment 24 ... Rubber stopper 28 ... Communication hole 30 ... Release film






Claims (6)

軟弱可撓性素材にて形成された薬剤バッグの内部空洞を弱シール部により複数の隔室に区画し、それぞれの隔室に薬剤を封入し、複数の隔室の一つを臨ませつつ外周が薬剤バッグに流密装着された排出口及び通常状態において前記排出口を薬剤バッグの内部空洞に対して閉鎖する閉鎖手段を具備し、前記閉鎖手段は、使用時の弱シール部開通の瞬間に薬剤バッグ内に惹起される衝撃的な流体力を受けたときの薬剤バッグの拡開変形と協働することにより排出口の閉鎖状態を解除可能であることを特徴とする薬剤収納封止体。   The inner cavity of the drug bag made of a soft and flexible material is divided into a plurality of compartments by weak seals, the medicine is enclosed in each compartment, and the outer periphery faces one of the plurality of compartments. And a closing means for closing the discharge opening with respect to the internal cavity of the medicine bag in a normal state, and the closing means is used at the moment of opening the weak seal portion during use. A drug storage sealing body capable of releasing a closed state of a discharge port by cooperating with an expansion deformation of a drug bag when receiving a shocking fluid force induced in the drug bag. 軟弱可撓性素材にて形成された薬剤バッグの内部空洞を弱シール部により複数の隔室に区画し、それぞれの隔室に薬剤を封入し、複数の隔室の一つを臨ませつつ外周が薬剤バッグに流密装着された排出口及び通常状態において前記排出口を薬剤バッグの内部空洞に対して閉鎖する分離可能型の閉鎖部材を具備し、前記閉鎖部材は、薬剤バッグの対抗内面に一体に保持されたことを特徴とする薬剤収納封止体。   The inner cavity of the drug bag made of a soft and flexible material is divided into a plurality of compartments by weak seals, the medicine is enclosed in each compartment, and the outer periphery faces one of the plurality of compartments. Is provided with a discharge port that is flow-tightly attached to the drug bag and a separable closure member that normally closes the discharge port with respect to the internal cavity of the drug bag, and the closure member is disposed on the inner surface of the drug bag. A sealed medicine container, which is held integrally. 軟弱可撓性素材にて形成された薬剤バッグの内部空洞を弱シール部により複数の隔室に区画し、それぞれの隔室に薬剤を封入し、複数の隔室の一つを臨ませつつ外周が薬剤バッグに流密装着された排出口を備え、前記排出口は薬剤バッグの外側における薬剤取出部と薬剤バッグの内側における薬剤流入部と薬剤流入部を閉鎖する剥離可能な閉鎖部材とから成り、前記剥離可能な閉鎖部材は薬剤バッグを構成する軟弱可撓性素材の対抗面に一体に固着されていることを特徴とする薬剤収納封止体。   The inner cavity of the drug bag made of a soft and flexible material is divided into a plurality of compartments by weak seals, the medicine is enclosed in each compartment, and the outer periphery faces one of the plurality of compartments. Includes a discharge port that is fluidly attached to the drug bag, and the discharge port includes a drug extraction part on the outside of the drug bag, a drug inflow part on the inside of the drug bag, and a peelable closing member that closes the drug inflow part. The peelable closure member is integrally fixed to a facing surface of a soft flexible material constituting the medicine bag. 軟弱可撓性素材にて形成された薬剤バッグの内部空洞を弱シール部により複数の隔室に区画し、それぞれの隔室に薬剤を封入し、複数の隔室の一つを臨ませつつ外周が薬液バッグに流密装着された排出口及び通常状態において前記排出口を閉鎖するように貼着された剥離膜を具備し、前記剥離膜は、薬剤バッグの対向面に、排出口に対する剥離膜の貼着より強固に貼着されたことを特徴とする薬剤収納封止体。   The inner cavity of the drug bag made of a soft and flexible material is divided into a plurality of compartments by weak seals, the medicine is enclosed in each compartment, and the outer periphery faces one of the plurality of compartments. Is provided with a discharge port that is flow-tightly attached to the drug solution bag and a release film that is attached so as to close the discharge port in a normal state, and the release film is provided on the opposite surface of the drug bag to the release film with respect to the discharge port. A sealed medicine storage body characterized in that it is adhered more firmly than the pasting. 軟弱可撓性素材にて形成された薬剤バッグの内部空洞を弱シール部により複数の隔室に区画し、それぞれの隔室に薬剤を封入し、外力により分離可能な作り付けの閉鎖部材を備えた排出口を複数の隔室の一つを臨ませつつ外周を薬剤バッグに流密装着し、排出口を閉鎖する閉鎖部材は薬剤バッグの対向内面に強固に固着されたことを特徴とする薬剤収納封止体。   The internal cavity of the drug bag made of a soft and flexible material is divided into a plurality of compartments by a weak seal, and a built-in closure member that encloses the medicine in each compartment and can be separated by an external force is provided. The medicine container is characterized in that the discharge port faces one of a plurality of compartments and the outer periphery thereof is tightly attached to the medicine bag, and the closing member for closing the discharge port is firmly fixed to the opposite inner surface of the medicine bag. Sealed body. 軟弱可撓性素材にて形成され、内部空洞が弱シール部により複数の隔室に区画された薬剤バッグ及び剥離可能型の閉鎖部材により閉鎖された排出口を準備し、それぞれの隔室に薬剤を封入し、複数の隔室の一つを臨むように排出口をその外周において薬液バッグに流密装着すると共に、排出口に設けられた剥離可能型の閉鎖部材はこれに対向する薬剤バッグの内面に閉鎖部材の剥離に要するより大きな固着力にて固着するようにしたことを特徴とする薬剤収納封止体の形成方法。






A medicine bag formed of a soft and flexible material and having an internal cavity divided into a plurality of compartments by weak seal portions and a discharge port closed by a detachable closing member are prepared, and a medicine is provided in each compartment. The discharge port is flow-tightly attached to the drug solution bag at the outer periphery so as to face one of the plurality of compartments, and the peelable closure member provided at the discharge port is provided on the opposite side of the drug bag. A method for forming a medicine container sealing body, wherein the inner surface is fixed to the inner surface with a larger fixing force required for peeling of the closing member.






JP2004203656A 2004-07-09 2004-07-09 Drug storage sealing body and method for forming drug storage sealing body Expired - Fee Related JP4599918B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004203656A JP4599918B2 (en) 2004-07-09 2004-07-09 Drug storage sealing body and method for forming drug storage sealing body

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004203656A JP4599918B2 (en) 2004-07-09 2004-07-09 Drug storage sealing body and method for forming drug storage sealing body

Publications (2)

Publication Number Publication Date
JP2006020964A true JP2006020964A (en) 2006-01-26
JP4599918B2 JP4599918B2 (en) 2010-12-15

Family

ID=35794644

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004203656A Expired - Fee Related JP4599918B2 (en) 2004-07-09 2004-07-09 Drug storage sealing body and method for forming drug storage sealing body

Country Status (1)

Country Link
JP (1) JP4599918B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009000343A (en) * 2007-06-22 2009-01-08 Ajinomoto Co Inc Multi-cell container
EP2177199A1 (en) * 2007-07-17 2010-04-21 Ajinomoto Co., Inc. Double-chamber container
CN111836611A (en) * 2018-03-13 2020-10-27 参天制药株式会社 Auxiliary device for eye drop
JP2022176222A (en) * 2018-09-18 2022-11-25 大日本印刷株式会社 Filling needle and filling device with the same, and soft container

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04364851A (en) * 1990-11-07 1992-12-17 Otsuka Pharmaceut Factory Inc Multi-chamber container
JPH055138U (en) * 1990-11-20 1993-01-26 株式会社大塚製薬工場 Infusion bag
JPH0614975A (en) * 1992-05-03 1994-01-25 Otsuka Pharmaceut Factory Inc Double-chamber container
JP2003305107A (en) * 2002-02-14 2003-10-28 Otsuka Pharmaceut Factory Inc Medicine discharge member and medical double-chamber container

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04364851A (en) * 1990-11-07 1992-12-17 Otsuka Pharmaceut Factory Inc Multi-chamber container
JPH055138U (en) * 1990-11-20 1993-01-26 株式会社大塚製薬工場 Infusion bag
JPH0614975A (en) * 1992-05-03 1994-01-25 Otsuka Pharmaceut Factory Inc Double-chamber container
JP2003305107A (en) * 2002-02-14 2003-10-28 Otsuka Pharmaceut Factory Inc Medicine discharge member and medical double-chamber container

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009000343A (en) * 2007-06-22 2009-01-08 Ajinomoto Co Inc Multi-cell container
EP2177199A1 (en) * 2007-07-17 2010-04-21 Ajinomoto Co., Inc. Double-chamber container
JP2013006060A (en) * 2007-07-17 2013-01-10 Ajinomoto Co Inc Multi-chamber container
EP2177199A4 (en) * 2007-07-17 2014-06-11 Ajinomoto Kk Double-chamber container
KR101532257B1 (en) * 2007-07-17 2015-06-29 아지노모토 가부시키가이샤 Double-chamber container
CN111836611A (en) * 2018-03-13 2020-10-27 参天制药株式会社 Auxiliary device for eye drop
JP2022176222A (en) * 2018-09-18 2022-11-25 大日本印刷株式会社 Filling needle and filling device with the same, and soft container
JP7327611B2 (en) 2018-09-18 2023-08-16 大日本印刷株式会社 Filling needle and filling device provided with the same, soft container

Also Published As

Publication number Publication date
JP4599918B2 (en) 2010-12-15

Similar Documents

Publication Publication Date Title
JP5088604B2 (en) Drug storage sealing body
KR100871204B1 (en) Medical liquid container and preparation-containing medical liquid container
JP5057172B2 (en) Multi-chamber container
JP5191145B2 (en) Infusion bag
JP4694307B2 (en) Medical container
JP4599918B2 (en) Drug storage sealing body and method for forming drug storage sealing body
JP2007190161A (en) Double-chamber container
JP4299553B2 (en) Medical container
JP4555094B2 (en) Medical container
JP4535840B2 (en) Manufacturing method of medical multi-chamber container
WO2010082649A1 (en) Dual-chamber container
JP5141949B2 (en) Multi-chamber container
JP4962733B2 (en) Multi-chamber container
JP2007260252A (en) Medical container
JP2008061669A (en) Multi-chamber container
JP2011131104A (en) Medical double-chamber container
JPH0639018A (en) Container for medial treatment
JP3888994B2 (en) Multi-chamber container
JP2008200367A (en) Medical container
JP2007185418A (en) Multi-chamber container
JP5223244B2 (en) Multi-chamber container
JP4365948B2 (en) Infusion bag
JP2011072454A (en) Multichamber container
JP2008036336A (en) Dual chamber container
JP5535722B2 (en) Medical container

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070706

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20091113

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091124

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100120

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100315

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100614

A911 Transfer of reconsideration by examiner before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20100623

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100831

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100913

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131008

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131008

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees